- Oops!Something went wrong.Please try again later.
Endo said the settlement includes no admission of wrongdoing by Endo or its subsidiaries.
The settlement severs Endo from an ongoing trial in lawsuits by New York Attorney General Letitia James and Suffolk and Nassau counties.
The deal came after McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH), and Johnson & Johnson (NYSE: JNJ) said they would move forward with a proposed $26 billion settlement resolving opioid cases against them.
Related Content: Opioid Settlement Of B Between Drug Companies, States.
In July, Endo agreed to pay million to settle a lawsuit by Tennessee local governments.
Last month, Wall Street Journal reported that Endo engaged Alvarez & Marsal to look into a potential financial restructuring.
Price Action: ENDP stock is up 15.20% at $2.42 during the premarket session on the last check Friday.
See more from Benzinga
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.